| Page | |||||
|---|---|---|---|---|---|
| Trustees' annual report (incorporating |
the | director's | report) | ||
| Independent examiner's report to the |
trustees | ||||
| Statement offinancial | activities (including | income and | |||
| expenditure account) |
|||||
| Statement offinancial | position | ||||
| Notes to the financial | statements | 11-22 |
| Reference | and adm | inistrative |
inistrative |
details |
|---|---|---|---|---|
| Registered | charity | name | The Livewell Foundation | |
| Charity registration | number | 1172401 | ||
| Company | registration | number | 10524700 | |
| Principal office and | registered | Local Care Centre | ||
| office | 200 Mount Gould Road | |||
| Mount Gould | ||||
| Plymouth | ||||
| United Kingdom |
||||
| PL4 7PY |
| 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|
| Unrestricted | Restricted | ||||||
| funds | funds | Total funds | Total funds | ||||
| Note | 8 | 8 | K | 5 | |||
| Income and endowments | |||||||
| Donations and legacies |
5 | 114,636 | 433 | 115,069 | 198,086 | ||
| Total income | 114,636 | 433 | 115,069 | 198,086 | |||
| Expenditure | |||||||
| Expenditure on charitable |
activities | 6,7 | 38,917 | 12,612 | 51,529 | 248,025 | |
| Total expenditure | 38,917 | 12,612 | 51,529 | 248,025 | |||
| Net income/(expenditure) | and net | ||||||
| movement in funds |
75,719 | (12,179) | 63,540 | (49,939) | |||
| Reconciliation offunds |
|||||||
| Total funds brought | forward | 184,024 | 245,671 | 429,695 | 479,634 | ||
| Total funds carried | forward | 259,743 | 233,492 | 493,235 | 429,695 |
| 2022 | 2021 | ||||
|---|---|---|---|---|---|
| Note | 5 | 6 | |||
| Current asseta | |||||
| Debtors | 753 | ||||
| Cash at bank and | in | hand | 508,641 | 428,942 | |
| 508,641 | 429,695 | ||||
| Net current asseR | 508,641 | 429,695 | |||
| Total assets less | current liabilities | 508,641 | 429,695 | ||
| Creditors: amounts | falling due after more than one year | 12 | 15,406 | ||
| Net assets | 493,235 | 429,695 | |||
| Funds ofthe charity | |||||
| Restricted funds |
233,492 | 245,671 | |||
| Unrestricted funds |
|||||
| Designated funds |
25,548 | 25,109 | |||
| General funds | 234,195 | 158,915 | |||
| Total charity funds | 14 | 493,235 | 429,695 |
| 2022 | 2021 | |||||
|---|---|---|---|---|---|---|
| Cash flows from operating | activities | |||||
| Net cash used in operating |
activities | 63,540 | ~49 938 | |||
| Increase/(Decrease) in debtors |
753 | (754) | ||||
| Increase/(Decrease) in creditors |
15,406 | ~16,779 | ||||
| Net cash generated from operating |
activities | 79,699 | ~17,533 | |||
| Cash flows from financing | activities | |||||
| Net cash provided by financing activities |
||||||
| Change in cash and cash |
equivalents | in | the period | 79,699 | (67,471) | |
| Cash and cash equivalents | at the beginning | ofthe period | 428,942 | 496413 | ||
| Cash and cash equivalents | at the end | of | the period | 508,641 | 428 942 |
| Donations and legacies |
|||
|---|---|---|---|
| Unrestricted | Restricted | Total Funds | |
| Funds | Funds | 2022 | |
| Donations | |||
| Donations | 14,636 | 14,636 | |
| Legacies | |||
| Legacies | 433 | 433 | |
| Grants | |||
| Grants receivable | 100,000 | 100,000 | |
| 114,636 | 433 | 115,069 | |
| Unrestricted | Restricted | Total Funds | |
| Funds | Funds | 2021 | |
| 5 | 5 | ||
| Donations | |||
| Donations | 13,498 | 13,498 | |
| Legacies | |||
| Legacies | 8,888 | 75,700 | 84,588 |
| Grants | |||
| Grants receivable | 100,000 | 100,000 | |
| 122,386 | 75,700 | 198,086 |
| Unrestricted | Restricted | Total | |||
|---|---|---|---|---|---|
| funds | funds | funds | |||
| 2022 | 2022 | 2022 | |||
| 6 | 6 | K | |||
| Other funds | 32,413 | 32,413 | |||
| Other legacy | |||||
| Mount Gould Legacy | 12,612 | 12,612 | |||
| Plym Neuro Fund | 1,147 | 1,147 | |||
| Tavistock General | Fund | 5,357 | 5,357 | ||
| Livewell Southwest | CIC Grant | ||||
| 38,917 | 12,612 | 51,529 | |||
| Unrestricted | Restricted | Total | |||
| funds | funds | funds | |||
| 2021 | 2021 | 2021 | |||
| 6 | K | ||||
| Other funds | 787 | 800 | 1,587 | ||
| Otherlegacy | 172 | 2,166 | 2,338 | ||
| Mount Gould Legacy | 136,064 | 136,064 | |||
| Plym Neuro Fund | 8,102 | 8,102 | |||
| Tavistock General | Fund | 1,934 | 1,934 | ||
| Livewell Southwest | CIC Grant | 98,000 | 98,000 | ||
| 108,995 | 139,030 | 248,025 | |||
| 7.Analysis ofexpenditure | by Fund | ||||
| Grant funding | Direct | Total | |||
| ofactivities | expenditure | funds | |||
| 2022f | 2022 6 |
2022 6 |
|||
| Other funds | 32,413 | 32,413 | |||
| Other legacy | |||||
| Mount Gould Legacy | 12,612 | 12,612 | |||
| Plym Neuro Fund | 1,147 | 1,147 | |||
| Tavistock General | Fund | 5,357 | 5,357 | ||
| Livewell Southwest | CIC Grant | ||||
| 51 529 | 51,529 | ||||
| Grant funding | Direct | Total | |||
| ofactivities | expenditure | funds | |||
| 2021 8 |
2021f | 2021f | |||
| Other funds | 1,587 | 1,587 | |||
| Other legacy | 2,337 | 2,337 | |||
| Mount Gould Legacy | 136,064 | 136,064 | |||
| Plym Neuro Fund | 8,103 | 8,103 | |||
| Tavistock General | Fund | 1,934 | 1,934 | ||
| Livewell Southwest | CIC Grant | 98000 | 98000 | ||
| 98000 | 150025 | 248,025 |
| 8.Analysis ofexp | endit | ure by Fund |
(Continued) | |||||
|---|---|---|---|---|---|---|---|---|
| Support | Totalfunds | |||||||
| Costs 2022f |
2022f | |||||||
| Otherfunds | 32,413 | 32,413 | ||||||
| Otherlegacy | ||||||||
| Mount Gould Legacy | 12,612 | 12,612 | ||||||
| Plym Neuro Fund | 1,147 | 1,147 | ||||||
| Tavistock General | Fund | 5,357 | 5,357 | |||||
| 51,529 | 51,529 | |||||||
| Support | Totalfunds | |||||||
| Costs 2021f |
2021f | |||||||
| Other funds | 1,587 | 1,587 | ||||||
| Other legacy Mount Gould Legacy |
2,338 136,064 |
2,338 136,064 |
||||||
| Plym Neuro Fund | 8,102 | 8,102 | ||||||
| Tavistock General | Fund | 1,934 | 1 934 | |||||
| 150025 | 150025 | |||||||
| Analysis ofsupport costs | ||||||||
| Other | Other | Mount | Plym | Tavistock | Total | |||
| funds | legacies | Gould | Neuro | General | funds | |||
| 2022f | 2022f | legacy 2022f |
2022f | 2022f | 2022f | |||
| Staff development | ||||||||
| Equipment Grants |
26,740 | 13,258 | 255 | 5,357 | 45,610 | |||
| Staff and patient | 1,242 | 225 | 1,100 | 2,567 | ||||
| welfare and amenities | ||||||||
| Support Costs | 4,431 | 871 | 208 | 3,352 | ||||
| 32,413 | 12,012 | 1 147 | 5 | 307 | 01,529 | |||
| Other | Other | Mount | Plym | Tavistock | Total | |||
| funds | legacies | Gould | Neuro | General | funds | |||
| 2021f | 2021f | legacy 2021f |
2021f | 2021 | 2021 | |||
| Staff development | 791 | 100 | 891 | |||||
| Equipment Grants |
4,378 | 103,128 | 5,850 | 1,762 | 115,118 | |||
| Staff and patient | 622 | 27,407 | 1,011 | 29,040 | ||||
| welfare and amenities Support Costs |
@33413 ~1587 |
2 330 2,338 |
4,738 136,064 |
1,141 8,102 |
1 | 172 934 |
~4975 150024 |
| 11. | During the period en Debtors |
ded 31 March 2022, no Trustee expenses have |
been incurred (20 |
21 -fNIL) |
|---|---|---|---|---|
| 2022 | 2021 | |||
| E | E | |||
| Trade debtors | 753 | |||
| 12. | Creditors: amounts | falling due after more than one year | ||
| 2022 f |
2021 E |
|||
| Trade creditors | 15,406 |
| Financial | Instruments | |||||
|---|---|---|---|---|---|---|
| 2022 E |
2021 f |
|||||
| Financial | assets | |||||
| Financial | assets measured | at fair value through | income and expenditure | 506,641 | 428 942 | |
| Fi i |
I | IFF'litu | ||||
| Financial | liabilities —creditors | 15,406 |
| Balance at | Income | Expenditure | Balance at | |||
|---|---|---|---|---|---|---|
| 1 April | 5 | K | 31 March | |||
| 2021 | 2022 | |||||
| 6 | ||||||
| 0 sl at U nm |
ctsd | und | ||||
| ~07 ~a1 |
||||||
| Plym Neuro Fund Tavistock General Fund |
20,513 4,596 25,109 |
6,943 6,943 |
(1,147) ~5357 ~6,504 |
26,309 ~704 25,548 |
||
| General funds | ||||||
| Otherfunds | 42,199 | 7,693 | (32,413) | 17~79 | ||
| Other legacies | 14,716 | 14,716 | ||||
| Livewell Southwest | Grant | 102,000 158,915 |
100,000 107,693 |
~32,413 | 202 000 234,195 |
|
| Total Unrestricted | funds | 184,024 | 114,636 | ~38017 | 259743 | |
| Restricted funds | ||||||
| Mount Gould Legacy | 163,838 | (12,612) | 151,226 | |||
| Plym Neuro Legacy | 9,098 | 9,098 | ||||
| Westhourne Legacy Other funds |
73,535 ~000 245,671 |
433 433 |
~12612 | 73,968 ~000 233,492 |
||
| ~771 11 0 |
420605 | 115000 | ~51029 | 493,235 |
| Statements offunds -prior period |
Statements offunds -prior period |
Statements offunds -prior period |
||||
|---|---|---|---|---|---|---|
| Balance at | Income | Expenditure | Balance at | |||
| 1 April | 6 | 5 | 31 March | |||
| 2020 6 |
2021f | |||||
| t)eat natedlunreetrlcted |
funds | |||||
| ~OI 9 f |
||||||
| Plym Neuro Fund Tavistock General |
Fund | 26,098 2,514 28612 |
2,518 ~,016 6534 |
(8,103) ~7.934 ~701137 |
20,513 4596 25109 |
|
| General funds | ||||||
| Other funds | 36,021 | 6,964 | (786) | 42,199 | ||
| Other legacies Livewell Southwest |
Grant | 6,000 100,000 142021 |
8,888 100,000 115,852 |
(172) ~90,000 ~80900 |
14,716 102,000 158,915 |
|
| 7 t 10 t I t d |
R d | 170633 | 122306 | ~708995 | 184024 | |
| Restricted funds | ||||||
| Mount Gould Legacy | 299,903 | (136,065) | 163,838 | |||
| Plym Neuro Legacy | 9,098 | 9,098 | ||||
| Westbourne Legacy Other funds |
309.001 | 75,700 75,700 |
(2,165) ~800 ~738030 |
73,535 ~800 245,671 |
||
| ~TI ff d |
479,634 | 198.080 | ~248025 | 429,695 |
| Summary offunds —curre |
nt period | ||||
|---|---|---|---|---|---|
| Balance at 1 April |
Income | Expendituref | Balance at 31 |
||
| 2021f | March 2022f |
||||
| Designated funds Generalfunds Restricted funds |
25,109 158,915 245,671 429,895 |
6,943 107,693 433 115090 |
(6,504) (32,413) ~12612 ~51529 |
25,548 234,195 233,492 493235 |
|
| Summary offunds —prior |
period | ||||
| Balance at 1 April |
Incomef | Expenditure | Balance at 31 |
||
| 2020 | March | ||||
| F | 2021f | ||||
| Designated funds General funds Restricted funds |
28,612 142,021 309,001 479,634 |
6,534 115,852 75 71IB 198,086 |
(10,037) (98,958) ~139,030 ~248,025 |
25,109 158,915 245671 429.695 |
|
| 16.Analysis ofnet assets | between | funds | |||
| Analysis of net assets |
between | funds— | |||
| Current year | |||||
| Unrestricted | Restricted | Total funds | |||
| Current assets Creditors due within one Total |
year | funds 2022f 259,743 ~4796 254,047 |
funds 2022f 248,898 508,641 ~1II,~10 ~15,406 2022f 238288 493 235 |
||
| Analysis of net assets |
between | funds— | |||
| prior year | |||||
| Unrestricted | Restricted | Total funds | |||
| funds 2021f |
funds 2021 F |
2021f | |||
| Current assets | 184,024 | 245 671 | 429,695 | ||
| Total | 184024 | 245 671 | 428 695 |
| 17.Reconciliation | 17.Reconciliation | of net | movement | movement | in funds to net cash flow from operating | in funds to net cash flow from operating | in funds to net cash flow from operating | activities | |
|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | ||||||||
| 6 | 6 | ||||||||
| Net income/expenditure activities) |
for the year (as per Statement | of Financial | 63,540 | (49,939) | |||||
| Adjustments | for: | ||||||||
| Decrease/(Increase) Increase/(Decrease) Net cash provided |
in debtors in creditors by/(used in) operating |
activities | 753 46466 79,699 |
(753) ~16779, ~67,471 |
|||||
| 18.Analysis | ofcash and | cash equivalents | |||||||
| 2022f | 2021 | ||||||||
| Cash in hand | 508,641 | 428,942 | |||||||
| Total cash and cash equivalents | 508,641 | 428,942 | |||||||
| 19.Analysis | ofchanges in |
net debt | |||||||
| At 1 April | Cash | At 31 | |||||||
| 2021 | flows | March | |||||||
| 6 | 6 | 2022 | |||||||
| 6 | |||||||||
| Cash at bank | and in hand | 426942 | 79,699 | 508,641 | |||||
| 428 942 | 79699 | 508641 |